Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Sodium-coupled monocarboxylate transporter 1 interacts with the RING finger- and PDZ domain-containing protein PDZRN3.

Otsuka Y, Furihata T, Nakagawa K, Ohno Y, Reien Y, Ouchi M, Wakashin H, Tsuruoka S, Anzai N.

J Physiol Sci. 2019 Jul;69(4):635-642. doi: 10.1007/s12576-019-00681-w. Epub 2019 May 16.

PMID:
31098988
2.

Large-Scale Quantitative Comparison of Plasma Transmembrane Proteins between Two Human Blood-Brain Barrier Model Cell Lines, hCMEC/D3 and HBMEC/ciβ.

Masuda T, Hoshiyama T, Uemura T, Hirayama-Kurogi M, Ogata S, Furukawa A, Couraud PO, Furihata T, Ito S, Ohtsuki S.

Mol Pharm. 2019 May 6;16(5):2162-2171. doi: 10.1021/acs.molpharmaceut.9b00114. Epub 2019 Apr 15.

PMID:
30983357
3.

Impaired mitochondrial oxidative phosphorylation capacity in epicardial adipose tissue is associated with decreased concentration of adiponectin and severity of coronary atherosclerosis.

Nakajima T, Yokota T, Shingu Y, Yamada A, Iba Y, Ujihira K, Wakasa S, Ooka T, Takada S, Shirakawa R, Katayama T, Furihata T, Fukushima A, Matsuoka R, Nishihara H, Dela F, Nakanishi K, Matsui Y, Kinugawa S.

Sci Rep. 2019 Mar 5;9(1):3535. doi: 10.1038/s41598-019-40419-7.

4.

Human mass balance, pharmacokinetics and metabolism of rovatirelin and identification of its metabolic enzymes in vitro.

Kobayshi K, Abe Y, Kawai A, Furihata T, Harada H, Endo T, Takeda H.

Xenobiotica. 2019 Feb 12:1-13. doi: 10.1080/00498254.2019.1580796. [Epub ahead of print]

PMID:
30747023
5.

Different Response Profiles of Gastrointestinal Cancer Cells to an L-Type Amino Acid Transporter Inhibitor, JPH203.

Muto Y, Furihata T, Kaneko M, Higuchi K, Okunushi K, Morio H, Reien Y, Uesato M, Matsubara H, Anzai N.

Anticancer Res. 2019 Jan;39(1):159-165. doi: 10.21873/anticanres.13092.

PMID:
30591453
6.

Polyamines stimulate the CHSY1 synthesis through the unfolding of the RNA G-quadruplex at the 5'-untraslated region.

Yamaguchi K, Asakura K, Imamura M, Kawai G, Sakamoto T, Furihata T, Linhardt RJ, Igarashi K, Toida T, Higashi K.

Biochem J. 2018 Dec 6;475(23):3797-3812. doi: 10.1042/BCJ20180672.

PMID:
30401686
7.

Synthesis of novel benzbromarone derivatives designed to avoid metabolic activation.

Ohe T, Umezawa R, Kitagawara Y, Yasuda D, Takahashi K, Nakamura S, Abe A, Sekine S, Ito K, Okunushi K, Morio H, Furihata T, Anzai N, Mashino T.

Bioorg Med Chem Lett. 2018 Dec 15;28(23-24):3708-3711. doi: 10.1016/j.bmcl.2018.10.023. Epub 2018 Oct 15.

PMID:
30389287
8.

Brain-Derived Neurotrophic Factor Improves Limited Exercise Capacity in Mice With Heart Failure.

Matsumoto J, Takada S, Kinugawa S, Furihata T, Nambu H, Kakutani N, Tsuda M, Fukushima A, Yokota T, Tanaka S, Takahashi H, Watanabe M, Hatakeyama S, Matsumoto M, Nakayama KI, Otsuka Y, Sabe H, Tsutsui H, Anzai T.

Circulation. 2018 Oct 30;138(18):2064-2066. doi: 10.1161/CIRCULATIONAHA.118.035212. No abstract available.

PMID:
30372141
9.

Impact of High Respiratory Exchange Ratio During Submaximal Exercise on Adverse Clinical Outcome in Heart Failure.

Kakutani N, Fukushima A, Yokota T, Katayama T, Nambu H, Shirakawa R, Maekawa S, Abe T, Takada S, Furihata T, Ono K, Okita K, Kinugawa S, Anzai T.

Circ J. 2018 Oct 25;82(11):2753-2760. doi: 10.1253/circj.CJ-18-0103. Epub 2018 Aug 31.

10.

Protein acetylation in skeletal muscle mitochondria is involved in impaired fatty acid oxidation and exercise intolerance in heart failure.

Tsuda M, Fukushima A, Matsumoto J, Takada S, Kakutani N, Nambu H, Yamanashi K, Furihata T, Yokota T, Okita K, Kinugawa S, Anzai T.

J Cachexia Sarcopenia Muscle. 2018 Oct;9(5):844-859. doi: 10.1002/jcsm.12322. Epub 2018 Aug 30.

11.

Differentiated HASTR/ci35 cells: A promising in vitro human astrocyte model for facilitating CNS drug development studies.

Kitamura K, Ito R, Umehara K, Morio H, Saito K, Suzuki S, Hashimoto M, Saito Y, Anzai N, Akita H, Chiba K, Furihata T.

J Pharmacol Sci. 2018 Aug;137(4):350-358. doi: 10.1016/j.jphs.2018.06.013. Epub 2018 Aug 9.

12.

Cancer-type organic anion transporting polypeptide 1B3 is a target for cancer suicide gene therapy using RNA trans-splicing technology.

Sun Y, Piñón Hofbauer J, Harada M, Wöss K, Koller U, Morio H, Stierschneider A, Kitamura K, Hashimoto M, Chiba K, Akita H, Anzai N, Reichelt J, Bauer JW, Guttmann-Gruber C, Furihata T.

Cancer Lett. 2018 Oct 1;433:107-116. doi: 10.1016/j.canlet.2018.06.032. Epub 2018 Jun 27.

PMID:
29960051
13.

Characterization and evaluation of graphene oxide scaffold for periodontal wound healing of class II furcation defects in dog.

Kawamoto K, Miyaji H, Nishida E, Miyata S, Kato A, Tateyama A, Furihata T, Shitomi K, Iwanaga T, Sugaya T.

Int J Nanomedicine. 2018 Apr 18;13:2365-2376. doi: 10.2147/IJN.S163206. eCollection 2018.

14.

Development of a Caco-2 Cell Line Carrying the Human Intestine-Type CES Expression Profile as a Promising Tool for Ester-Containing Drug Permeability Studies.

Ishizaki Y, Furihata T, Oyama Y, Ohura K, Imai T, Hosokawa M, Akita H, Chiba K.

Biol Pharm Bull. 2018;41(5):697-706. doi: 10.1248/bpb.b17-00880.

15.

In Vivo Introduction of mRNA Encapsulated in Lipid Nanoparticles to Brain Neuronal Cells and Astrocytes via Intracerebroventricular Administration.

Tanaka H, Nakatani T, Furihata T, Tange K, Nakai Y, Yoshioka H, Harashima H, Akita H.

Mol Pharm. 2018 May 7;15(5):2060-2067. doi: 10.1021/acs.molpharmaceut.7b01084. Epub 2018 Apr 11.

PMID:
29638135
16.

Cancer-Type OATP1B3 mRNA in Extracellular Vesicles as a Promising Candidate for a Serum-Based Colorectal Cancer Biomarker.

Morio H, Sun Y, Harada M, Ide H, Shimozato O, Zhou X, Higashi K, Yuki R, Yamaguchi N, Hofbauer JP, Guttmann-Gruber C, Anzai N, Akita H, Chiba K, Furihata T.

Biol Pharm Bull. 2018;41(3):445-449. doi: 10.1248/bpb.b17-00743.

17.

Development of a New Conditionally Immortalized Human Liver Sinusoidal Endothelial Cells.

Zhu M, Koibuchi A, Ide H, Morio H, Shibuya M, Kamiichi A, Tsubota A, Anzai N, Akita H, Chiba K, Furihata T.

Biol Pharm Bull. 2018;41(3):440-444. doi: 10.1248/bpb.b17-00661.

18.

Deletion of NAD(P)H Oxidase 2 Prevents Angiotensin II-Induced Skeletal Muscle Atrophy.

Kadoguchi T, Takada S, Yokota T, Furihata T, Matsumoto J, Tsuda M, Mizushima W, Fukushima A, Okita K, Kinugawa S.

Biomed Res Int. 2018 Jan 2;2018:3194917. doi: 10.1155/2018/3194917. eCollection 2018.

19.

Soluble CD40 ligand disrupts the blood-brain barrier and exacerbates inflammation in experimental autoimmune encephalomyelitis.

Masuda H, Mori M, Umehara K, Furihata T, Uchida T, Uzawa A, Kuwabara S.

J Neuroimmunol. 2018 Mar 15;316:117-120. doi: 10.1016/j.jneuroim.2018.01.001. Epub 2018 Jan 3.

PMID:
29329699
20.

Extracellular Vesicles as Biomarkers for the Detection of a Tumor Marker Gene in Epidermolysis Bullosa-Associated Squamous Cell Carcinoma.

Sun Y, Woess K, Kienzl M, Leb-Reichl VM, Feinle A, Wimmer M, Zauner R, Wally V, Luetz-Meindl U, Mellerio JE, Fuentes I, South AP, Bauer JW, Reichelt J, Furihata T, Guttmann-Gruber C, Piñón Hofbauer J.

J Invest Dermatol. 2018 May;138(5):1197-1200. doi: 10.1016/j.jid.2017.11.022. Epub 2017 Dec 2. No abstract available.

21.

Characterization of an L-Carnitine Transport System in Murine Photoreceptor Cell Line.

Ohno Y, Otsuka Y, Nohara M, Furihata T, Kuse Y, Itoh Y, Hara H, Anzai N.

Biol Pharm Bull. 2017;40(12):2110-2116. doi: 10.1248/bpb.b17-00461.

22.

A New Conditionally Immortalized Human Fetal Brain Pericyte Cell Line: Establishment and Functional Characterization as a Promising Tool for Human Brain Pericyte Studies.

Umehara K, Sun Y, Hiura S, Hamada K, Itoh M, Kitamura K, Oshima M, Iwama A, Saito K, Anzai N, Chiba K, Akita H, Furihata T.

Mol Neurobiol. 2018 Jul;55(7):5993-6006. doi: 10.1007/s12035-017-0815-9. Epub 2017 Nov 11.

PMID:
29128907
23.
24.

Cancer-type OATP1B3 mRNA has the potential to become a detection and prognostic biomarker for human colorectal cancer.

Sun Y, Harada M, Shimozato O, Souda H, Takiguchi N, Nabeya Y, Kamijo T, Akita H, Anzai N, Chiba K, Furihata T.

Biomark Med. 2017 Aug;11(8):629-639. doi: 10.2217/bmm-2017-0098. Epub 2017 Jun 8.

PMID:
28592144
25.

Premedication with fast-acting oxycodone hydrochloride hydrate effectively reduced oxaliplatin-induced severe vascular pain.

Nagao S, Furihata M, Fukagawa K, Furihata T, Matsuhashi Y, Wada T.

J Infect Chemother. 2017 Jul;23(7):493-497. doi: 10.1016/j.jiac.2017.02.006. Epub 2017 Mar 10.

PMID:
28285948
26.

Human organic anion transporter 2 is an entecavir, but not tenofovir, transporter.

Furihata T, Morio H, Zhu M, Suzuki Y, Ide H, Tsubota A, Fu Z, Anzai N, Chiba K.

Drug Metab Pharmacokinet. 2017 Feb;32(1):116-119. doi: 10.1016/j.dmpk.2016.09.004. Epub 2016 Sep 23.

PMID:
27916488
27.

The novel heart-specific RING finger protein 207 is involved in energy metabolism in cardiomyocytes.

Mizushima W, Takahashi H, Watanabe M, Kinugawa S, Matsushima S, Takada S, Yokota T, Furihata T, Matsumoto J, Tsuda M, Chiba I, Nagashima S, Yanagi S, Matsumoto M, Nakayama KI, Tsutsui H, Hatakeyama S.

J Mol Cell Cardiol. 2016 Nov;100:43-53. doi: 10.1016/j.yjmcc.2016.09.013. Epub 2016 Sep 25.

28.

Polyamines release the let-7b-mediated suppression of initiation codon recognition during the protein synthesis of EXT2.

Imamura M, Higashi K, Yamaguchi K, Asakura K, Furihata T, Terui Y, Satake T, Maegawa J, Yasumura K, Ibuki A, Akase T, Nishimura K, Kashiwagi K, Linhardt RJ, Igarashi K, Toida T.

Sci Rep. 2016 Sep 21;6:33549. doi: 10.1038/srep33549.

29.

Does massive intraabdominal free gas require surgical intervention?

Furihata T, Furihata M, Ishikawa K, Kosaka M, Satoh N, Kubota K.

World J Gastroenterol. 2016 Aug 28;22(32):7383-8. doi: 10.3748/wjg.v22.i32.7383.

30.

Involvement of ESE-3, epithelial-specific ETS factor family member 3, in transactivation of the ABCB1 gene via pregnane X receptor in intestine-derived LS180 cells but not in liver-derived HepG2 cells.

Kameyama N, Kobayashi K, Shimizu S, Yamasaki Y, Endo M, Hashimoto M, Furihata T, Chiba K.

Drug Metab Pharmacokinet. 2016 Oct;31(5):340-348. doi: 10.1016/j.dmpk.2016.05.004. Epub 2016 Jun 3.

PMID:
27567379
31.

Dipeptidyl peptidase-4 inhibitor improved exercise capacity and mitochondrial biogenesis in mice with heart failure via activation of glucagon-like peptide-1 receptor signalling.

Takada S, Masaki Y, Kinugawa S, Matsumoto J, Furihata T, Mizushima W, Kadoguchi T, Fukushima A, Homma T, Takahashi M, Harashima S, Matsushima S, Yokota T, Tanaka S, Okita K, Tsutsui H.

Cardiovasc Res. 2016 Sep;111(4):338-47. doi: 10.1093/cvr/cvw182. Epub 2016 Jul 21.

PMID:
27450980
32.

Serum myostatin levels are independently associated with skeletal muscle wasting in patients with heart failure.

Furihata T, Kinugawa S, Fukushima A, Takada S, Homma T, Masaki Y, Abe T, Yokota T, Oba K, Okita K, Tsutsui H.

Int J Cardiol. 2016 Oct 1;220:483-7. doi: 10.1016/j.ijcard.2016.06.231. Epub 2016 Jun 27.

33.

Investigation of Drug-Drug Interactions Between Ritobegron, a Selective β3 -Adrenoceptor Agonist, With Probenecid in Healthy Men.

Abe Y, Nakano Y, Kanazawa T, Furihata T, Endo T, Kobayashi M.

Clin Pharmacol Drug Dev. 2016 May;5(3):201-7. doi: 10.1002/cpdd.212. Epub 2015 Sep 29.

PMID:
27163499
34.

Direct renin inhibitor ameliorates insulin resistance by improving insulin signaling and oxidative stress in the skeletal muscle from post-infarct heart failure in mice.

Fukushima A, Kinugawa S, Takada S, Matsumoto J, Furihata T, Mizushima W, Tsuda M, Yokota T, Matsushima S, Okita K, Tsutsui H.

Eur J Pharmacol. 2016 May 15;779:147-56. doi: 10.1016/j.ejphar.2016.03.022. Epub 2016 Mar 14.

35.

The experimental model of transition from compensated cardiac hypertrophy to failure created by transverse aortic constriction in mice.

Furihata T, Kinugawa S, Takada S, Fukushima A, Takahashi M, Homma T, Masaki Y, Tsuda M, Matsumoto J, Mizushima W, Matsushima S, Yokota T, Tsutsui H.

Int J Cardiol Heart Vasc. 2016 Mar 16;11:24-28. doi: 10.1016/j.ijcha.2016.03.007. eCollection 2016 Jun.

36.

Overexpression of TSC-22 (transforming growth factor- β-stimulated clone-22) causes marked obesity, splenic abnormality and B cell lymphoma in transgenic mice.

Uchida D, Kawamata H, Omotehara F, Miwa Y, Horiuchi H, Furihata T, Tachibana M, Fujimori T.

Oncotarget. 2016 Mar 22;7(12):14310-23. doi: 10.18632/oncotarget.7308.

37.

Characterization of release profile of ornithine carbamoyltransferase from primary rat hepatocytes treated with hepatotoxic drugs: Implications for its unique potential as a drug-induced liver injury biomarker.

Furihata T, Aizawa T, Koibuchi A, Zhu M, Yamasaki Y, Shibuya M, Chiba K.

Drug Metab Pharmacokinet. 2016 Feb;31(1):102-105. doi: 10.1016/j.dmpk.2015.11.005. Epub 2015 Dec 6.

PMID:
26825849
38.

Establishment and characterization of a new conditionally immortalized human astrocyte cell line.

Furihata T, Ito R, Kamiichi A, Saito K, Chiba K.

J Neurochem. 2016 Jan;136(1):92-105. doi: 10.1111/jnc.13358. Epub 2015 Oct 8.

39.

Sesamin prevents decline in exercise capacity and impairment of skeletal muscle mitochondrial function in mice with high-fat diet-induced diabetes.

Takada S, Kinugawa S, Matsushima S, Takemoto D, Furihata T, Mizushima W, Fukushima A, Yokota T, Ono Y, Shibata H, Okita K, Tsutsui H.

Exp Physiol. 2015 Nov;100(11):1319-30. doi: 10.1113/EP085251. Epub 2015 Oct 1.

40.

Influencing factors on serum 25-hydroxyvitamin D3 levels in Japanese chronic hepatitis C patients.

Atsukawa M, Tsubota A, Shimada N, Yoshizawa K, Abe H, Asano T, Ohkubo Y, Araki M, Ikegami T, Kondo C, Itokawa N, Nakagawa A, Arai T, Matsushita Y, Nakatsuka K, Furihata T, Chuganji Y, Matsuzaki Y, Aizawa Y, Iwakiri K.

BMC Infect Dis. 2015 Aug 19;15:344. doi: 10.1186/s12879-015-1020-y.

42.

Differential inhibition features of direct-acting anti-hepatitis C virus agents against human organic anion transporting polypeptide 2B1.

Furihata T, Fu Z, Suzuki Y, Matsumoto S, Morio H, Tsubota A, Matsumoto S, Chiba K.

Int J Antimicrob Agents. 2015 Oct;46(4):381-8. doi: 10.1016/j.ijantimicag.2015.05.013. Epub 2015 Jun 24.

PMID:
26163159
43.

AST-120 ameliorates lowered exercise capacity and mitochondrial biogenesis in the skeletal muscle from mice with chronic kidney disease via reducing oxidative stress.

Nishikawa M, Ishimori N, Takada S, Saito A, Kadoguchi T, Furihata T, Fukushima A, Matsushima S, Yokota T, Kinugawa S, Tsutsui H.

Nephrol Dial Transplant. 2015 Jun;30(6):934-42. doi: 10.1093/ndt/gfv103. Epub 2015 Apr 15.

44.

Repeated Duodenal Stump Perforation Using a Stapling Device Following Subtotal Gastrectomy With Roux-en-Y Reconstruction for Advanced Gastric Cancer: Lessons From a Rare Case.

Furihata T, Furihata M, Satoh N, Kosaka M, Ishikawa K, Kubota K.

Int Surg. 2015 Apr;100(4):726-32. doi: 10.9738/INTSURG-D-14-00266.1.

45.

Interferon-λ3 polymorphisms in pegylated-interferon-α plus ribavirin therapy for genotype-2 chronic hepatitis C.

Ishiguro H, Abe H, Seki N, Sugita T, Aida Y, Itagaki M, Sutoh S, Shimada N, Furihata T, Tsubota A, Aizawa Y.

World J Gastroenterol. 2015 Apr 7;21(13):3904-11. doi: 10.3748/wjg.v21.i13.3904.

46.

Hydrocortisone enhances the barrier properties of HBMEC/ciβ, a brain microvascular endothelial cell line, through mesenchymal-to-endothelial transition-like effects.

Furihata T, Kawamatsu S, Ito R, Saito K, Suzuki S, Kishida S, Saito Y, Kamiichi A, Chiba K.

Fluids Barriers CNS. 2015 Mar 5;12:7. doi: 10.1186/s12987-015-0003-0. eCollection 2015.

47.

Serum brain-derived neurotropic factor level predicts adverse clinical outcomes in patients with heart failure.

Fukushima A, Kinugawa S, Homma T, Masaki Y, Furihata T, Yokota T, Matsushima S, Takada S, Kadoguchi T, Oba K, Okita K, Tsutsui H.

J Card Fail. 2015 Apr;21(4):300-6. doi: 10.1016/j.cardfail.2015.01.003. Epub 2015 Jan 30.

48.

Unique expression features of cancer-type organic anion transporting polypeptide 1B3 mRNA expression in human colon and lung cancers.

Sun Y, Furihata T, Ishii S, Nagai M, Harada M, Shimozato O, Kamijo T, Motohashi S, Yoshino I, Kamiichi A, Kobayashi K, Chiba K.

Clin Transl Med. 2014 Nov 18;3:37. doi: 10.1186/s40169-014-0037-y. eCollection 2014.

49.

A giant lymphatic cyst of the adrenal gland: report of a rare case and review of the literature.

Furihata M, Iida Y, Furihata T, Ito E.

Int Surg. 2015 Jan;100(1):2-8. doi: 10.9738/INTSURG-D-14-00125.1. Review.

50.

Angiotensin II can directly induce mitochondrial dysfunction, decrease oxidative fibre number and induce atrophy in mouse hindlimb skeletal muscle.

Kadoguchi T, Kinugawa S, Takada S, Fukushima A, Furihata T, Homma T, Masaki Y, Mizushima W, Nishikawa M, Takahashi M, Yokota T, Matsushima S, Okita K, Tsutsui H.

Exp Physiol. 2015 Mar;100(3):312-22. doi: 10.1113/expphysiol.2014.084095. Epub 2015 Feb 12.

Supplemental Content

Loading ...
Support Center